Physicians' Academy for Cardiovascular Education

Are very low LDL-c levels safe?

Expert Meeting on LDL-c & PCSK9 inhibition in high CV risk patients

5' education - Jan. 23, 2019 - John Kastelein, Lluis Masana

Video navigation menu

  • Are very low LDL-c levels safe and desirable in the current therapeutic climate? 00:22
  • Are there any problems with biological functions with very low LDL-c levels? 01:35
  • Is there any reason for fears about neurological problems with low LDL-c levels? 03:20
  • The benefit/risk ratio of new therapies 05:31

Educational information

This video was recorded during an expert meeting among cardiologists and internists, focussing on the topic of 'LDL-c & PCSK9 inhibition in high CV risk patients - Balancing Science, Guidelines and Daily Cardiology Practice'.

The objectives of the meeting were to:

Other topics covered in this series

Other lectures part of this educational series are:

Faculty

Prof. John J.P Kastelein, internist, Amsterdam University Medical Centers, The Netherlands

Prof. Lluis Masana, internist, University Rovira and Virgili, Reus-Tarragona, Spain

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Funding for the Expert Meeting was provided by an unrestricted educational grant from Amgen. The sponsor did not attend and influence the video recording.

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: